Abstract
Tumor cells from a murine fibrosarcoma (FSa) produce plasminogen activator (PA), a protease that converts the zymogen plasminogen into the trypsin-like enzyme plasmin. Several studies indicate that tumor cell invasion is accompanied by proteolysis and that PA, generated by highly malignant cells, is by far the most ubiquitous protease associated with malignant transformation. Subpopulations of FSa cells were isolated by using density gradient centrifugation and the ability of these populations to form lung colonies was compared with their associated levels of PA production. Five populations of cells from a murine fibrosarcoma were separated in continuous gradients of Renografin in the density range 1-05–1·18 g/cm2. The PA activities of an unseparated control cell lysate and cell lysates of the five separated populations were determined by using [125I]fibrin as a substrate in a reaction between cell lysate and plasminogen. The assay was based on the release of digested [125I]fibrin from the surface of Petri dishes into the supernatant solution, and the results were expressed as a percentage of the total radioactivity. The cell populations collected at densities of 1-05 and 109 (B1, B2) were the more clonogenic with relative clonogenic efficiencies of 2·6 and 3·3 times that of the unseparated tumor population, respectively. Analysis for PA demonstrated that enzyme formation was restricted mostly to these two populations. Cells from populations 4 and 5 did not secrete increased amounts of PA and had reduced clonogenic efficiencies compared with the unseparated FSa control population. These results are consistent with the hypothesis that PA activity is correlated with the clonogenicity of tumor subpopulations isolated from a heterogeneous and complex tumor system such as the FSa.
Similar content being viewed by others
References
Aggeler, J., Kapp, L. N., Tseng, S. C. G., andWerb, Z., 1982, Regulation of protein secretion in Chinese hamster ovary cells by cell cycle position and cell density.Experimental Cell Research,139, 275–283.
Astrup, T., 1978, Fibronolysis-an overview, inProgress in Chemical Fibronolysis and Thrombolysis, edited by J. F. Davidson, M. M. Samma, R. M. Rowan and P. C. Desnoyers, Vol. 3 (Raven Press, New York), pp. 1–57.
Beers, W. H., Strickland, S., andReich, E., 1975, Ovarian plasminogen activator: relationship to ovulational hormonal regulation.Cell,6, 387–394.
Brock, A. W., Swartzendruber, D. E., andGrdina, D. J., 1982, Kinetic heterogeneity in density-separated murine fibrosarcoma subpopulations.Cancer Research,42, 4999–5003.
Colombi, M., Barlati, S., Magdelenat, H., andFiszer-Szafarz, B'. 1984, Relationship between multiple forms of plasminogen activator in human breast tumors and plasma, and the presence of metastases in lymph nodes.Cancer Research,44, 2971–2975.
Fidler, I. J., 1978, Tumor heterogeneity and the biology of cancer invasion and metastasis.Cancer Research,38, 2651–2660.
Grdina, D. J., Milas, L., Hewitt, R. R., andWithers, H. R., 1973, Buoyant density separation of human blood cells in renografin gradients.Experimental Cell Research,81, 250–254.
Grdina, D. J., Basic, I., Mason, K. A., andWithers, H. R., 1975, Radiation response of clonogenic cell populations separated from a fibrosarcoma.Radiation Research,63, 483–493.
Grdina, D. J., Hittelman, W. N., White, R. A., andMeistrich, M. L., 1977, Relevance of density, size and DNA content of tumor cells to the lung colony assay.British Journal of Cancer,36, 659–669.
Grdina, D. J., Peters, L. J., Jones, S., andChan, E., 1978, Separation of cells from a murine fibrosarcoma on the basis of size. I. Relationship between cell size and age as modified by growthin vivo orin vitro.Journal of the National Cancer Institute,61, 209–214.
Helmkamp, R. W., Goodland, R. L., Bale, W. F., Spar, J. L., andMutschler, L. E., 1960, High specific activity iodination ofγ-globulin with iodine-131 monochloride.Cancer Research,20, 1495–1500.
Markus, G., Takita, H., Camiolo, S. M., Corasati, J. G., Evers, J. L., andHabika, G. H., 1980, Content and characterization of plasminogen activators in human lung tumors and normal lung tissue.Cancer Research,40, 841–848.
Nagy, B., Ban, J., andBrdar, B., 1977, Fibronolysis associated with human neoplasia production of plasminogen activator by human tumors.International Journal of Cancer,19, 614–620.
Nagy, B., Ban, J., andBrdar, B., 1982, The fibrinolytic activity of human tumor cells in culture and its inhibition by sera.Periodicum Biologorum,84, 332–335.
Ossowski, L., andReich, E., 1980, Experimental model for quantitative study of metastasis.Cancer Research,40, 2300–2309.
Ossowski, L., andReich, E., 1983, Antibodies to plasminogen activator inhibit human tumor metastasis.Cell,35, 611–619.
Post, G., 1975, Production of a serin protease with macrophage migration inhibitory factor activity by virus transformed cells and human tumor cell lines.Cancer Research,35, 2558–2566.
Quigley, J. P., Ossowski, L., andReich, E., 1974, Plasminogen, the serum proenzyme activated by factors from cells transformed by oncogenic viruses.Journal of Biological Chemistry,249, 4303–4311.
Strauli, P., Barrett, A. J., andBaici, A., 1980,Proteinases and Tumor Invasion (Raven Press, New York).
Strickland, S., Reich, E., andSherman, M., 1976, Plasminogen activator in early embryogenesis: enzyme production of trophoblast and parietal endoderm.Cell,9, 231–240.
Suit, H. D., andSuchato, D., 1967, Hyperbaric oxygen and radiotherapy of fibrosarcoma and of squamous cell carcinoma.Radiology,89, 713–719.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nagy, B., Grdina, D.J. Plasminogen activator activity in clonogenic cell populations separated from a murine fibrosarcoma. Clin Exp Metast 7, 243–250 (1989). https://doi.org/10.1007/BF01787027
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01787027